Overnutrition: Clinical Trials

13,652 trials for Overnutrition, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8503 completed, 1682 unknown, 1340 recruiting, 608 active not recruiting. 8047 Not applicable, 967 Phase 2, 784 Phase 1, 669 Phase 3, 584 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable8047Completed 5223, Unknown 991, Recruiting 706, Active not recruiting 341, Not yet recruiting 293, Terminated 260, Withdrawn 157, Enrolling by invitation 65, Suspended 11
Phase 2967Completed 599, Recruiting 102, Unknown 66, Active not recruiting 58, Terminated 58, Not yet recruiting 40, Withdrawn 37, Enrolling by invitation 4, Suspended 3
Phase 1784Completed 509, Recruiting 105, Active not recruiting 45, Not yet recruiting 40, Unknown 34, Terminated 32, Withdrawn 17, Enrolling by invitation 1, Suspended 1
Phase 3669Completed 376, Recruiting 86, Unknown 59, Terminated 46, Active not recruiting 45, Not yet recruiting 38, Withdrawn 16, Suspended 2, Enrolling by invitation 1
Phase 4584Completed 333, Unknown 81, Recruiting 47, Not yet recruiting 40, Terminated 33, Active not recruiting 25, Withdrawn 20, Enrolling by invitation 4, Suspended 1
Early Phase 1122Completed 64, Unknown 16, Recruiting 13, Withdrawn 9, Active not recruiting 6, Not yet recruiting 5, Terminated 5, Suspended 3, Enrolling by invitation 1

Follow Overnutrition: new trials by email Literature Review of Overnutrition trials Research Report on Overnutrition

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic
Polylactose, Placebo - Obesity, Adolescent, Obesity, Childhood
Not applicableWithdrawnUniversity of Minnesota2028-05-012025-07-11
A Study of Body Fat Distribution and Airway Mechanics in Healthy Adults
Body positioning - Healthy Volunteers Only
Not applicableNot yet recruitingMaurizio F. Cereda, MD202028-01-012025-06-18
Adiposity Distribution in Acute Respiratory Failure
PEEP Titration Using Electrical Impedance Tomography (EIT), Body Positioning: Supine and Prone - Acute Hypoxemic Respiratory Failure, Obesity
Not applicableNot yet recruitingMaurizio F. Cereda, MD802028-01-012025-06-13
Community Active and Healthy Families Pragmatic Trial
Community Active and Healthy Families Intensive Health Behavior and Lifestyle Treatment - Child Obesity
Phase 4Not yet recruitingUniversity of Colorado, Denver4162028-01-012026-10-09
AI-INFORMED PEER-MENTORING BEHAVIORAL INTERVENTION FOR OBESITY AND CARDIOVASCULAR DISEASE PRIMARY PREVENTION IN YOUTH
AI-informed behavioral intervention, Standard behavioral intervention, Health Education - Obesity (Disorder)
Not applicableNot yet recruitingAikaterini Karaivazoglou8402027-09-012026-04-14
Modifying Diet to Improve Gut Microbiome
DASH diet, standard American diet - Obesity
Not applicableNot yet recruitingH. Lee Moffitt Cancer Center and Research Institute282027-07-012026-09-17
Simplifying Diet Tracking in a Digital Weight Loss Intervention
Simplified Dietary Self-Monitoring, Detailed Dietary Self-Monitoring, Core Behavioral Weight Loss Intervention - Overweight, Obesity
Not applicableNot yet recruitingStanford University3282027-05-012026-05-28
Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)
ESG with OverStitch - Type 2 Diabetes Mellitus (T2D), Obesity (BMI>30)
Not applicableNot yet recruitingBoston Scientific Corporation502027-04-012026-09-24
Can Two Dietary Interventions Maintain Weight Loss for 12 Months After GLP-1 Therapy in Adults With Overweight/Obesity?
NutriAct plus, Rescue VLCD - Obesity & Overweight, Weight Loss Maintenance
Not applicableNot yet recruitingKnut Mai2922027-03-012026-07-20
Cardiometabolic Effects of the Recommended Daily Pecan Intake Dose
Pecan, Control - Nutrition, Healthy, Dyslipidemia
Not applicableNot yet recruitingUniversity of Georgia902027-03-012026-08-11
Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutide Plus Placebo in Older Obese Adults
LUM-201, Placebo, Semagludtide - Obesity & Overweight
Phase 2Not yet recruitingLumos Pharma2022027-02-152026-08-10
BRE-13: Mediterranean Diet
Explore the effect of MedDiet vs. Usual Diet on Fatty Acid Profile, Explore the effect of MedDiet vs. Usual Diet on Breast Tumor Tissue, Explore the effect of MedDiet vs. Usual Diet on Lipids - Dietary Assessment, Dietary and Lifestyle Behaviour Change
Not applicableNot yet recruitingUniversity of Illinois at Chicago302027-02-152026-10-09
Effects of Tirzepatide on Gut Microbiota and Gastrointestinal Function After Drug Withdrawal in Obese Patients
Tirzepatide - Obesity / Overweight
Not yet recruitingNanjing First Hospital, Nanjing Medical University802027-02-012026-10-15
Semaglutide for Low Back Pain
Semaglutide (administered by PDS290 pen-injector), Placebo (administered by PDS290 pen-injector) - Lower Back Pain, Obesity (BMI>30)
Phase 2Not yet recruitingWashington University School of Medicine2502027-02-012026-07-28
EMBodied psychOsocial Impacts of Weight Stigma During Pregnancy (EMBODY): A Prospective Cohort Study
Weight Stigma, Pregnancy Outcomes
Not yet recruitingMonash University8002027-02-012026-10-16
Prospective Study of an Explainable AI Tool to Support Biliopancreatic Limb Selection in One-Anastomosis Gastric Bypass
One-anastomosis gastric bypass with observed biliopancreatic limb length - Obesity, Severe Obesity
Not yet recruitingThe Society of Bariatric and Metabolic Surgeons of Kazakhstan1202027-01-152026-09-14
AMAZE 13: A Research Study Investigating How Well the Medicine Zenagamtide Helps People in Asia With Excess Body Weight Lose Weight
Zenagamtide, Placebo ( matched to Zenagamtide) - Obesity, Overweight
Phase 3Not yet recruitingNovo Nordisk A/S4002027-01-072026-08-24
Target Physiotherapy Versus Exercise Support Intervention for Bladder-bowel Dysfunction in Adolescents With Obesity
Target physiotherapy, Exercise support intervention, Usual obesity care - Bladder-Bowel Dysfunction, Obesity & Overweight
Not applicableNot yet recruitingUniversity of Lisbon2372027-01-042026-07-23
Addressing Food Access and Physical Activity to Improve Diabetes Prevention Outcomes Among Underserved African Americans
Culturally-tailored, enhanced adaption of Diabetes Prevention Program - Diabetes, Physical Activity
Not applicableNot yet recruitingUniversity of Missouri, Kansas City4082027-01-042026-06-09
Patient-centred Intervention With Virtual Support for Obesity and Kidney Transplant Access
Semaglutide, Virtual Weight Management Coaching - Obesity, Chronic Kidney Disease
Phase 4Not yet recruitingKristin Clemens8802027-01-012026-10-05

Showing 20 of 13652. Sign in to see all of them.

Narrower conditions

Obesity (11331)  ·  Overweight (3523)  ·  Weight Loss (1195)  ·  Motor Activity (1151)  ·  Pediatric Obesity (1121)  ·  Diabetes Mellitus, Type 2 (1114)  ·  Obesity, Morbid (931)  ·  Diabetes Mellitus (823)  ·  Insulin Resistance (787)  ·  Metabolic Syndrome (732)  ·  Hypertension (587)  ·  Cardiovascular Diseases (480)  ·  Inflammation (324)  ·  Body Weight (296)  ·  Obesity, Abdominal (289)

Broader conditions

Nutritional and Metabolic Diseases (13633)  ·  Nutrition Disorders (13551)  ·  Pathological Conditions, Signs and Symptoms (13527)  ·  Signs and Symptoms (13492)  ·  Body Weight (13185)  ·  Overweight (10126)  ·  Metabolic Diseases (3275)  ·  Glucose Metabolism Disorders (3085)  ·  Endocrine System Diseases (2236)  ·  Behavior (2102)  ·  Obesity (1836)  ·  Hyperinsulinism (1366)  ·  Body Weight Changes (1330)  ·  Diabetes Mellitus (1230)

Interventions

Exercise (494)  ·  Diet (238)  ·  semaglutide (220)  ·  Bariatric Surgery (163)  ·  Tirzepatide (147)  ·  Liraglutide (126)  ·  Metformin (125)  ·  Gastric Bypass (117)  ·  Caloric Restriction (107)  ·  Nutrition Assessment (99)  ·  Control Groups (90)  ·  Resistance Training (84)  ·  Diet Therapy (81)  ·  Standard of Care (73)  ·  Sodium Chloride (72)

Sponsors

Novo Nordisk A/S (204)  ·  University of Colorado, Denver (119)  ·  Eli Lilly and Company (116)  ·  Mayo Clinic (112)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (104)  ·  Washington University School of Medicine (94)  ·  Pennington Biomedical Research Center (91)  ·  The Miriam Hospital (91)  ·  University of Copenhagen (90)  ·  Maastricht University Medical Center (89)  ·  Massachusetts General Hospital (87)  ·  University of Alabama at Birmingham (84)  ·  Yale University (81)  ·  Duke University (80)  ·  University of Pennsylvania (79)

Countries

United States (5548)  ·  Canada (652)  ·  China (633)  ·  France (583)  ·  United Kingdom (508)  ·  Spain (476)  ·  Turkey (Türkiye) (434)  ·  Italy (407)  ·  Denmark (398)  ·  Germany (378)  ·  Brazil (321)  ·  Netherlands (290)  ·  Mexico (238)  ·  Sweden (228)  ·  Egypt (224)

Top investigators

Samuel Klein, MD (22)  ·  Jack A Yanovski, M.D. (20)

Results publications

PMID 38375882, PMID 33512717, PMID 29718281, PMID 38376518, PMID 26210388, PMID 26708836, PMID 30122305, PMID 30230252, PMID 33238176, PMID 40839263, PMID 41029405, PMID 28386912, PMID 28950422, PMID 30651576, PMID 33782940, PMID 38271099, PMID 42014131, PMID 22085317, PMID 23987123, PMID 24500151, PMID 24570244, PMID 26599819, PMID 27482610, PMID 27817208, PMID 28473337, PMID 31004409, PMID 32002540, PMID 32909523, PMID 33567185, PMID 37652841, PMID 38698650, PMID 39226070, PMID 39952695, PMID 40705619, PMID 11832527, PMID 15479938, PMID 17715408, PMID 18673303, PMID 19858703, PMID 20573639, PMID 20798995, PMID 21932999, PMID 22449319, PMID 22963820, PMID 23661689, PMID 23703580, PMID 24586896, PMID 25343235, PMID 26132939, PMID 26418188

NIH funding

2025 (55), 2023 (38), 2017 (26), 2019 (22), 2018 (16), 2014 (15), 2015 (15), 2016 (14), 2009 (13), 2008 (11), UL1TR001082 (9), P50MD017338 (6), R01DK059853 (6), UL1TR000135 (6), 2005 (5)